Purchase Order HHSN271201700113P
Award Date 1/12/17
Potential Completion Date 1/12/22
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute on Drug Abuse awarded a $79,569.86 firm fixed-price purchase order to Salient Science & Technology LLC for pharmaceutical business development consulting services. The contract, designated as a Total Small Business set-aside, was awarded on February 27, 2017, with an ultimate completion date of April 14, 2022. Work is being performed in Bethesda, Maryland, and the engagement focuses on business development consulting support for the institute's pharmaceutical...
- This is a federal purchase order contract awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to Johnson, Graham, a small business sole proprietorship. The contract is for $114,749.40 and was set aside for small businesses. The contractor will provide senior-level medicinal chemistry consulting services to support NIH's Blueprint Neurotherapeutics Network drug discovery and development programs, with a focus on neuroscience and addiction...
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Detke Biopharma Consulting LLC, a for-profit limited liability company, for clinical pharmacology consulting services. The contract has a ceiling value of $29,138.12 and a period of performance ending on January 13, 2022. The contract is not associated with a larger vehicle and does not have a set-aside designation. The contract was awarded on January 12, 2017 under the Major...
- This is a $90,000.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), which is a civilian agency of the U.S. government. The contract, which does not have a set-aside designation, is for the "SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT)" program and was awarded to DC Chemicals LIMITED, a for-profit limited liability company, on July 9, 2015. The period of performance for this contract ends on November 30, 2015.
- This is a $112,329.81 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Maris Solutions LLC, a self-certified small disadvantaged business, woman-owned small business. The contract does not have a set-aside designation and the ultimate completion date is August 31, 2016. The contract is for unspecified products or services, as the original solicitation was not provided. There is no indication of any major subcontractors or that...
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health, to Med Associates, Inc., a for-profit, woman-owned small business manufacturer and supplier of specialized scientific laboratory equipment and software. The contract award, valued at $18,898.50, is for the delivery of products that support research into substance use disorders, neurological processes, addiction mechanisms, and behavioral...
- <p>This is a $113,258.16 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse, a civilian federal agency, to Maris Solutions LLC, a small disadvantaged woman-owned business. The contract has a period of performance ending on February 29, 2016, and was awarded on August 31, 2015. The contract does not have a set-aside designation. The contract award does not reference a larger contract vehicle.</p>
- The National Institute of Neurological Disorders and Stroke (NINDS) has awarded a $12,000 purchase order to NDC Medchem Consulting LLC, a small business entity located in Poway, California, for medicinal chemistry and bioactivity assay development consulting services. The contract was awarded on September 29, 2025, with an ultimate completion date of September 28, 2026. This award is designated as a Total Small Business set-aside, limiting competition to qualified small business concerns. The...
- This is a $245,400 firm-fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to RPK Associates, LLC, a small business, for biological therapeutics product development subject matter expert consulting services. The contract supports the development of therapeutic biotechnology products (biologics) and includes option periods through November 16, 2025. The contract was awarded...
- The U.S. National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services' National Institutes of Health, awarded a $19,600.00 Purchase Order contract to Lin Jiunn, a small business located in Ambler, Pennsylvania. The contract is for a Subject Matter Expert Consultant in Drug Metabolism Pharmacokinetics (DMPK) to support NIDA's NIH Blueprint Neurotherapeutics Network program. The contract has a one-year base period with an estimated minimum of 20 annual hours and a...
This is a $18,963.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to NINDS PHARMAC LLC for medicinal chemistry consulting services. The contract has a Total Small Business set-aside designation. The contract was awarded on January 12, 2017 and has an ultimate completion date of January 12, 2022. The place of performance is Bethesda, Maryland.
Generated 8/22/24, 3:18 PM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Medicinal Chemistry Consulting Services in relation to Pharmaceutical Development | HHS-NIH-NIDA-SSSA-CSS-17-087 | Department of Health and Human Services National Institutes of Health | Award Notice 1/1 | 12/16/16, 10:50 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00009 | Funding Only Action | ($10k) | 8/21/24 | |
| P00008 | Funding Only Action | ($7k) | 3/9/22 | |
| P00007 | Supplemental Agreement for work within scope | $0 | 10/14/21 | |
| P00006 | Exercise an Option | $3.0k | 9/24/21 | |
| P00005 | Exercise an Option | $7.5k | 12/22/20 |